Synopsys entered an accelerated share repurchase agreement with JPMorgan Chase Bank, National Association on October 5, 2026, to repurchase $1 billion of stock, initially receiving approximately 1,735,000 shares and settling any remainder by January 5, 2027.
SNPS · Synopsys Inc · Documents
$455.20
-7.49 (-1.62%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$87.23B
Shares
191.64M
Volume · Nov 13
2.01M
Avg daily vol (3M)
2.14M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Oct 5
Current report
8-K
Other events
Sep 30
Investor event
Investor Day
Synopsys raised its long-term IP growth outlook to high-teens, expects application-optimized IP to deliver a billion dollar by 2030, and sees ANSYS revenue synergies in 2027 toward 400 million by 2029.
Aug 26
Aug 26
Quarterly report
10-Q
FY2026 Q3, ended Jul 31
Quarterly report for FY2026 Q3
AI summary on its way
Revenue $2.48B
▲ 42.4%
Net income $545.8M
▲ 125.1%
Diluted EPS $2.84
▲ 89.3%
Aug 26
Aug 26
Aug 12
Current report
8-K
Events of Aug 9
Director or officer change, or executive pay
AI summary on its way
May 27
May 27
May 27
Current report
8-K
Events of May 26
Entered into a material agreement, Director or officer change, or executive pay, Regulation FD disclosure
AI summary on its way
May 27
Quarterly report
10-Q
FY2026 Q2, ended Apr 30
Quarterly report for FY2026 Q2
AI summary on its way
Revenue $2.28B
▲ 41.9%
Net income $17.11M
▼ 95.0%
Diluted EPS $0.09
▼ 95.9%
Apr 20
Current report
8-K
Events of Apr 16
Director or officer change, or executive pay, Shareholder vote results
AI summary on its way
Mar 3
Mar 2
Feb 25
Feb 25
Feb 25
Quarterly report
10-Q
FY2026 Q1, ended Jan 31
Quarterly report for FY2026 Q1
AI summary on its way
Revenue $2.41B
▲ 65.5%
Net income $64.96M
▼ 78.0%
Diluted EPS $0.34
▼ 82.0%
Feb 19
Feb 19
Current report
8-K
Events of Feb 14
Director or officer change, or executive pay, Regulation FD disclosure
AI summary on its way
Feb 19
Feb 19
2025
Dec 22
Annual report
10-K
FY2025, ended Oct 31
Annual report for FY2025
Revenue $7.05B
▲ 15.1%
Net income $1.33B
▼ 41.1%
Diluted EPS $8.04
▼ 44.6%
Dec 10
Earnings call
Q4 2025 earnings call
Dec 10
Current report
8-K
Financial results
Dec 1
Current report
8-K
Unregistered sale of equity, Regulation FD disclosure
Nov 12
Current report
8-K
Events of Nov 9
Exit or restructuring costs
Nov 4
Current report
8-K
Events of Nov 1
Director or officer change, or executive pay, Regulation FD disclosure
Sep 18
Current report
8-K/A
Events of Jul 17
Director or officer change, or executive pay
Sep 9
Earnings call
Q3 2025 earnings call
Sep 9
Current report
8-K
Financial results
Sep 9
Quarterly report
10-Q
FY2025 Q3, ended Jul 31
Quarterly report for FY2025 Q3
Revenue $1.74B
▲ 14.0%
Net income $242.51M
▼ 40.6%
Diluted EPS $1.50
▼ 42.5%
Jul 17
Jul 14
Current report
8-K
Other events
Jul 3
Current report
8-K
Events of Jul 2
Other events
May 29
Current report
8-K
Regulation FD disclosure, Other events
May 28
Earnings call
Q2 2025 earnings call
May 28
Current report
8-K
Financial results
May 28
Quarterly report
10-Q
FY2025 Q2, ended Apr 30
Quarterly report for FY2025 Q2
Revenue $1.6B
▲ 10.3%
Net income $345.33M
▲ 18.2%
Diluted EPS $2.21
▲ 17.6%
Apr 11
Current report
8-K
Events of Apr 10
Director or officer change, or executive pay, Shareholder vote results
Mar 17
Mar 5
Current report
8-K
Events of Mar 3
Entered into a material agreement
Feb 27
Current report
8-K
Other events
Feb 27
Registration statement
S-3ASR
Registration statement
Feb 26
Earnings call
Q1 2025 earnings call
Feb 26
Current report
8-K
Financial results
Feb 26
Quarterly report
10-Q
FY2025 Q1, ended Jan 31
Quarterly report for FY2025 Q1
Revenue $1.46B
▼ 3.7%
Net income $295.68M
▼ 34.2%
Diluted EPS $1.89
▼ 34.6%
Feb 14
Proxy statement
DEF 14A
Meeting Apr 10, 2025
Proxy statement
Feb 14
Annual report to holders
ARS
Annual report to holders
Feb 14
Proxy statement
DEFA14A
Proxy statement
2024
Dec 19
Annual report
10-K
FY2024, ended Oct 31
Annual report for FY2024
Revenue $6.13B
▲ 15.2%
Net income $2.26B
▲ 84.0%
Diluted EPS $14.51
▲ 83.2%
Showing 1–50 of 177 documents
Key facts
CIK
883241
CUSIP
871607107
13F (30d)
1108 filings
1044 filers
Visit website
Investor relations